Hudson Bay Capital Management’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-650,920
| Closed | -$6.53M | – | 1167 |
|
|
2022
Q3 | $6.53M | Sell |
650,920
-36,608
| -5% | -$367K | 0.06% | 275 |
|
|
2022
Q2 | $6.81M | Buy |
687,528
+175,000
| +34% | +$1.73M | 0.05% | 271 |
|
|
2022
Q1 | $5.05M | Buy |
512,528
+79,146
| +18% | +$780K | 0.07% | 342 |
|
|
2021
Q4 | $4.23M | Hold |
433,382
| – | – | 0.04% | 390 |
|
|
2021
Q3 | $4.24M | Hold |
433,382
| – | – | 0.06% | 393 |
|
|
2021
Q2 | $4.27M | Buy |
433,382
+36,902
| +9% | +$363K | 0.05% | 386 |
|
|
2021
Q1 | $3.92M | Sell |
396,480
-3,519
| -0.9% | -$34.8K | 0.05% | 365 |
|
|
2020
Q4 | $4.02M | Buy |
+399,999
| New | +$4.02M | 0.04% | 258 |
|